Propanc Biopharma PPCB Stock
Propanc Biopharma Price Chart
Propanc Biopharma PPCB Financial and Trading Overview
| Propanc Biopharma stock price | 1.64 USD |
| Previous Close | 1.87 USD |
| Open | 1.78 USD |
| Bid | 0.11 USD x 100 |
| Ask | 2.09 USD x 100 |
| Day's Range | 1.66 - 1.98 USD |
| 52 Week Range | 1.56 - 270.25 USD |
| Volume | 25.58K USD |
| Avg. Volume | 141.71K USD |
| Market Cap | 4.12M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 0.0031726554 |
| EPS (TTM) | 570.5 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PPCB Valuation Measures
| Enterprise Value | 5.25M USD |
| Trailing P/E | 0.0031726554 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.3294723 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.286 |
Trading Information
Propanc Biopharma Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -97.63% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 270.25 USD |
| 52 Week Low | 1.56 USD |
| 50-Day Moving Average | 2.46 USD |
| 200-Day Moving Average | 22.83 USD |
PPCB Share Statistics
| Avg. Volume (3 month) | 141.71K USD |
| Avg. Daily Volume (10-Days) | 85.07K USD |
| Shares Outstanding | 2.28M |
| Float | 1.63M |
| Short Ratio | 0.1 |
| % Held by Insiders | 14.84% |
| % Held by Institutions | 0.81% |
| Shares Short | 24.68K |
| Short % of Float | 1.20% |
| Short % of Shares Outstanding | 1.08% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -62.30% |
| Return on Equity (ttm) | -126.97% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -18373020 USD |
| Net Income Avi to Common (ttm) | -19293176 USD |
| Diluted EPS (ttm) | 570.5 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 443.7K USD |
| Total Cash Per Share (mrq) | 0.2 USD |
| Total Debt (mrq) | 573.87K USD |
| Total Debt/Equity (mrq) | 5.3 USD |
| Current Ratio (mrq) | 2.366 |
| Book Value Per Share (mrq) | 0.777 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4132839 USD |
| Levered Free Cash Flow (ttm) | 46.03M USD |
Profile of Propanc Biopharma
| Country | United States |
| State | VIC |
| City | Camberwell |
| Address | 302, 6 Butler Street |
| ZIP | 3124 |
| Phone | 61 3 9882 0780 |
| Website | https://www.propanc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc. was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. The company was incorporated in 2007 and is based in Camberwell, Australia.
Q&A For Propanc Biopharma Stock
What is a current PPCB stock price?
Propanc Biopharma PPCB stock price today per share is 1.64 USD.
How to purchase Propanc Biopharma stock?
You can buy PPCB shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Propanc Biopharma?
The stock symbol or ticker of Propanc Biopharma is PPCB.
Which industry does the Propanc Biopharma company belong to?
The Propanc Biopharma industry is Biotechnology.
How many shares does Propanc Biopharma have in circulation?
The max supply of Propanc Biopharma shares is 2.28M.
What is Propanc Biopharma Price to Earnings Ratio (PE Ratio)?
Propanc Biopharma PE Ratio is 0.00286591 now.
What was Propanc Biopharma earnings per share over the trailing 12 months (TTM)?
Propanc Biopharma EPS is 570.5 USD over the trailing 12 months.
Which sector does the Propanc Biopharma company belong to?
The Propanc Biopharma sector is Healthcare.